MedTrace Logo

DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy

NCT04825795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4007

Last updated 2023-02-08

No results posted yet for this study

Summary

The study aim is to evaluate whether DPP4-inhibitor could reduce coronary atherosclerosis assessed by CT scan in patients receiving insulin for diabetes mellitus. In this retrospective study, changes in obstructive coronary artery disease prevalence and coronary calcium burden between two coronary CT scans will be compared in patients with and without receiving DPP4-inhibitor.

Conditions

Interventions

DRUG

DPP4-inhibitor

Prescription of DPP4-inhibitor during the period between the two coronary CT scan

DRUG

No DPP4-inhibitor

No prescription of DPP4-inhibitor during the period between the two coronary CT scan

Sponsors & Collaborators

  • The Catholic University of Korea

    lead OTHER

Principal Investigators

  • Sang-Hyun Ihm, MD,PhD · Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2021-02-24
Completion
2021-03-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04825795 on ClinicalTrials.gov